HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. by Daniel P. Bradley (10306893)

Protective effect of SMND-309 against liver injury in acute liver injury model mice. by Yao Dong (3308124)

ATPase activity of Pns10 does not contribute to mitochondrial energy impairment or ROS accumulation in Sf9 cells. by Lianshun Zheng (22086585)

Co-transformed cells grow preferentially as tumors in peritoneal cavities. by Mitchell Hayes (5334887)

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. by Tamjid A. Chowdhury (14149846)

Effects of 1466 on capsid and pgRNA encapsidation compared to known CAM-A and CAM-E inhibitors. by Daniel P. Bradley (10306893)

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)

1466 inhibits capsid accumulation independent of HBV replication. by Daniel P. Bradley (10306893)

Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

“…Some <i>N</i>-hydroxypyridinedione (HPD) HBV RNaseH inhibitors significantly reduced accumulation of capsids in HBV-replicating cells. …”

The mRNA (A) and protein (B) levels of <i>NlPHB2</i> in viruliferous and nonviruliferous <i>N. lugens</i> determined by RT-qPCR and Western blot assays at 6 dpvf. by Lianshun Zheng (22086585)

A working model for the RRSV Pns10-promoted RRSV infection in <i>N. lugens</i> through inducing NlNDUFS1-mediated mitochondrial apoptosis. by Lianshun Zheng (22086585)

“…During viral infection, RRSV Pns10 impairs the mitochondrial complex I activity through disrupting the NlNDUFS1 and NlPHB2 interaction. This impairment of mitochondrial complex I activity results in a significant decrease of ATP production and an increase of mitochondrial ROS production, which causes mitochondrial apoptosis to facilitate RRSV infection in <i><i>N. lugens</i></i>.…”

Forest Plot of Multivariate Odds Ratios for Risk Factors Associated with Nerve Injury 90 Days After Total Knee Arthroplasty. by Rahul H. Jayaram (21463899)

Subjects:

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

Subjects:

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

Subjects:

Relative frequency of type I (dark gray) and type II (light gray) errors in 10 000 replicas for each initial condition of the simulation. by Farrokh Habibzadeh (12256529)

Subjects:

PVS_ratio changes, ΔPVS_ratio, for different radiation doses within each treatment period: 0M–3M(a), 3M–12M(b), and 12M–FollowUp(c). by Ruitian Song (11045127)

Subjects:

Predicted probability of infection symptoms due to forest cover for 2011 and 2016. by Amit Timilsina (15203538)

Subjects:

Patient demographic information at four time points. by Ruitian Song (11045127)

Subjects:

T1w images (top row) and segmented PVS overlaid on T1w images (bottom row) at TP of 0M, 3M, 12M, and FollowUp for a typical patient. by Ruitian Song (11045127)

Subjects:

Box plots representing comparisons of PVS volumes across different variables with statistical comparison annotations for TP(a), DOSE(b), Shunt(c), Anesthesia(d), and Sex(e). by Ruitian Song (11045127)

Subjects: